Monolac 150mg Capsule 10'S

Ulcer/Reflux/Flatulence Rx required

Best Price* ₹ 16.00 MRP ₹ 20.00
(Inclusive of all taxes) *10 Capsule(s) in a Strip * Mkt: Monichem Healthcare Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout


MONOLAC contains Ranitidine which belongs to a group of medicines called H2 receptor antagonists. It acts by reducing the amount of acid produced in your stomach. It is used for the treatment and prevention of ulcers of stomach and intestine. It also heals and stop problems caused by heartburn (acid in the food pipe) or indigestion. Ranitidine reduces the secretion of gastric acid stimulated either by food or drugs like non-steroidal anti-inflammatories (NSAIDs), often used to treat arthritis. It reduces gastric acid production by reversibly binding to histamine (H2) receptors present in the lining of gastric parietal cells.

Along with this treatment, your doctor might recommend you, to take enough rest and drink plenty of fluids. Sticking to simple meals and avoiding rich or spicy food can also be beneficial. Avoid smoking and consumption of alcohol during this therapy, as it may reduce the chances of healing and worsen the ulcers. The most common side effects of taking this medicine are stomach pain, constipation or nausea, although not everybody gets them. Before taking this medicine, inform your doctor if you have stomach cancer, kidney problems, porphyria or diabetes. Ask your doctor for advice before taking any medicine, if you are pregnant or breast-feeding.


  • Treat stomach and duodenal ulcers, heartburn (acid in the food pipe) and indigestion in both adults and in children above 3 years of age
  • Reduce infections in your stomach, when taken with antibiotics
  • Treat Zollinger-Ellison Syndrome (a disease of pancreas which causes ulceration of the stomach, duodenum, gut and gullet)
  • Stop acid reflux, while under anesthesia during an operation


Ranitidine causes reversible binding to histamine (H2) receptors present in the lining of gastric parietal cells. Binding of histamine to H2 receptors triggers the production of stomach pain. Ranitidine selectively and competitively antagonizes the effects of histamine at H2-receptors and reduces the secretion of gastric acid.


Always take MONOLAC as directed by your physician. Swallow the medicine as a whole with a glass of water. Do not crush or chew the medicine. This medicine can be taken with or without food. Your doctor will decide the correct dose and duration of therapy depending upon your age, weight and disease condition.



  • allergic reactions (such as skin rash, flaking skin, swelling of the face, eyelids, lips, mouth or tongue, fever, sudden wheezing, fluttering or tightness of the chest, chest pain, feeling faint or collapse)
  • a change in the amount of urine passed and its colour
  • feeling confused
  • slow or irregular heartbeats


  • stomach pain
  • constipation
  • feeling sick (nausea)


Feeling sick (nausea):

Try taking this medicine with, or just after, a meal. Stick to simple meals. Do not eat rich or spicy food.


Eat fibre rich foods like fresh fruit, vegetables and cereals. Drink plenty of water. Exercise more regularly.

Stomach pain:

Try to rest and relax. You can eat and drink slowly or have smaller and frequent meals. Keeping a heat pad on your stomach may also help. If still pain persists, speak to your doctor.



MONOLAC should be used with caution in pregnant women. Consult your doctor before taking this medicine.


MONOLAC should be used with caution in breastfeeding women. Consult your doctor before taking this medicine.


Do not drive or operate any machines if your ability is affected by this medicine.


Avoid consumption of alcohol while taking this medicine.


MONOLAC should be taken with caution in patients with severe kidney disease. Consult your doctor for advice.


MONOLAC should be taken with caution in patients with severe liver disease. Consult your doctor for advice.


Do not take this medicine if you are allergic (hypersensitive) to ranitidine.


MONOLAC should be taken with caution in patients with lung disease. Consult your doctor for advice.


Before taking this medicine, inform your doctor if you:

  • have stomach cancer, porphyria, unintended weight loss associated with acid indigestion, long term breathing problems, diabetes or any problems with your immune system


Talk to your doctor, if you are taking,

  • medicines used for pain and swelling (including arthritis) such as indometacin or aspirin
  • medicines used to treat diabetes (e.g. glipizide, or glibenclamide)
  • medicines used to treat heart problems (e.g. procainamide, N-acetylprocainamide or propranolol)
  • medicines used to induce sleep (e.g. triazolam or midazolam)
  • medicines used to treat infections (e.g. raltegravir, atazanavir, delavirdine, ketoconazole, itraconazole or cefpodoxime)
  • medicines used to treat cancer (e.g. erlotinib, gefitinib or lapatinib)
  • warfarin (used to stop blood clots)
  • lidocaine (a local anaesthetic)
  • diazepam (used to treat anxiety)
  • phenytoin (used to treat epilepsy)
  • theophylline (used to treat long term breathing problems)
  • sucralfate (used for stomach ulcers)


Drug :   Ranitidine
Pharmacological Category :   Histamine H2 Antagonist
Therapeutic Indication :  

Gastroesophageal reflux disease (GERD), Peptic ulcer disease

Dosage Forms :   Tablet, Syrup, Injection


Store below 20-25°C and keep out of reach of children.


Can MONOLAC be used for gas?

No. It is intended to treat stomach ulcers, heart burn and acid reflux. Consult your doctor before taking.

Can MONOLAC be taken during pregnancy?

It should not be taken during pregnancy unless considered essential by your doctor. Discuss the risks and benefits with your doctor.

Can MONOLAC be suitable for children?

Yes. It is suitable for use in children aged above 3 years. Your doctor will decide the dose and duration of therapy depending upon your child’s age and weight.


1. KD. Tripathi. Drugs for Peptic ulcer and Gastroesophageal Reflux Disease. Essentials of medical pharmacology. Seventh edition. 2013. Page – 649-650.

2. John L. Wallace and Keith A. Sharkey. Pharmacotherapy of Gastric acidity, Peptic ulcer and Gastroesophageal Reflux disease. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1313-1314.

3. Gerald G. Briggs and Roger K. Freeman. R. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 3356-2775.

4. AstraZeneca. Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer. NIH U.S. National Library of Medicine [Revised on July 2010] [Accessed 24th November 2020]

5. E P Woodings, G T Dixon, C Harrison, P Carey, and D A Richards. Ranitidine-a new H2-receptor antagonist. NCBI; PMC US National Library of Medicine, National Institute of Health. March 1980. [Accessed 24th November 2020]

6. Accord Healthcare Limited. Electronic Medicines Compendium (EMC); [Revised on August 2014] [Accessed 24th November 2020]

7. Glaxo Wellcome SA, Omega Pharma International & Famar ltalia S.p.A. Electronic Medicines Compendium (EMC); [Revised on August 2019] [Accessed 24th November 2020]


    Net Qty
    1 N
    Item Weight
    17.5 g
    Hsn Code
Rdinxt 150mg Capsule 10'S
Prescription Ulcer/Reflux/Flatulence Rx required
Out of stock

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2022. All Rights Reserved.